ORIGINAL RESEARCH
Published on 19 Jul 2021
Berberine Reduces Aβ42 Deposition and Tau Hyperphosphorylation via Ameliorating Endoplasmic Reticulum Stress
doi 10.3389/fphar.2021.640758
- 3,621 views
- 39 citations
- Frontiers in Neuroscience
- Neuropharmacology
- Research Topics
- Drug Repurposing in Neurodegenerative and Neuropsychiatric Disorders
Drug Repurposing in Neurodegenerative and Neuropsychiatric Disorders
37k
Total downloads
172k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
MINI REVIEW
Published on 28 Jun 2021
Role of Plant-Derived Natural Compounds in Experimental Autoimmune Encephalomyelitis: A Review of the Treatment Potential and Development Strategy
doi 10.3389/fphar.2021.639651
- 3,966 views
- 13 citations
ORIGINAL RESEARCH
Published on 31 May 2021
Methylprednisolone Induces Neuro-Protective Effects via the Inhibition of A1 Astrocyte Activation in Traumatic Spinal Cord Injury Mouse Models
doi 10.3389/fnins.2021.628917
- 6,012 views
- 29 citations
REVIEW
Published on 26 May 2021
Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?
doi 10.3389/fnins.2021.656475
- 8,092 views
- 18 citations
REVIEW
Published on 24 May 2021
Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders
doi 10.3389/fphar.2021.667874
- 5,601 views
- 28 citations
REVIEW
Published on 30 Apr 2021
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?
doi 10.3389/fnins.2021.657714
- 28,519 views
- 17 citations
ORIGINAL RESEARCH
Published on 22 Apr 2021
Emulated Clinical Trials from Longitudinal Real-World Data Efficiently Identify Candidates for Neurological Disease Modification: Examples from Parkinson’s Disease
doi 10.3389/fphar.2021.631584
- 7,016 views
- 11 citations
ORIGINAL RESEARCH
Published on 15 Apr 2021
Bexarotene Impairs Cognition and Produces Hypothyroidism in a Mouse Model of Down Syndrome and Alzheimer’s Disease
doi 10.3389/fphar.2021.613211
- 3,353 views
- 12 citations
REVIEW
Published on 29 Mar 2021
Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
doi 10.3389/fnins.2021.656921
- 8,852 views
- 22 citations
REVIEW
Published on 23 Mar 2021
Drug Repurposing in the Treatment of Traumatic Brain Injury
doi 10.3389/fnins.2021.635483
- 10,968 views
- 18 citations
REVIEW
Published on 19 Mar 2021
Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience
doi 10.3389/fnins.2021.653377
- 9,899 views
- 22 citations
ORIGINAL RESEARCH
Published on 29 Dec 2020
Farnesyl Transferase Inhibitor Lonafarnib Enhances α7nAChR Expression Through Inhibiting DNA Methylation of CHRNA7 and Increases α7nAChR Membrane Trafficking
doi 10.3389/fphar.2020.589780
- 2,777 views
- 1 citation
Published in
Frontiers in Neuroscience
- Neuropharmacology
Participating Journals
Frontiers in Neurology
NeuropharmacologyOffline
- 2.7 impact factor
- 4.9 citescore
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Impact
- 172kTopic views
- 131kArticle views
- 37kArticle downloads